Found: 5
Select item for more details and to access through your institution.
Sequential combination of flavopiridol with Taxol synergistically suppresses human ovarian carcinoma growth.
- Published in:
- Archives of Gynecology & Obstetrics, 2015, v. 291, n. 1, p. 143, doi. 10.1007/s00404-014-3408-0
- By:
- Publication type:
- Article
Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01632-6
- By:
- Publication type:
- Article
Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01632-6
- By:
- Publication type:
- Article
Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.
- Published in:
- Journal of Ovarian Research, 2014, v. 7, n. 1, p. 155, doi. 10.1186/s13048-014-0121-3
- By:
- Publication type:
- Article
Selective suppression of autocatalytic caspase-3 driven by two-step transcriptional amplified human telomerase reverse transcriptase promoter on ovarian carcinoma growth in vitro and in mice.
- Published in:
- Oncology Reports, 2014, v. 32, n. 1, p. 225, doi. 10.3892/or.2014.3204
- By:
- Publication type:
- Article